Despite personnel turnover of late, Eventide Gilead remains a decent offering at the right price. Recent adjustments to some share classes’ Morningstar Medalists Ratings don’t reflect a shift in conviction in the team or approach but instead result from Morningstar’s revised method for calculating excess return opportunities.
Eventide Gilead Class C ETCGX
- NAV / 1-Day Return 53.71 / +0.83 %
- Total Assets 3.3B
-
Adj. Expense Ratio
2.180%
- Expense Ratio 2.180%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 60%
USD | NAV as of Jul 15, 2026 | 1-Day Return as of Jul 15, 2026, 12:43 AM GMT+0
Morningstar’s Analysis ETCGX
Will ETCGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 32.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Guardant Health Inc | 5.53 | 148M | Healthcare |
Xometry Inc Ordinary Shares - Class A | 4.35 | 117M | Industrials |
Lam Research Corp | 4.13 | 111M | Technology |
Us Bank Mmda - Usbgfs 9 | 3.88 | 104M | Cash and Equivalents |
ASML Holding NV ADR | 3.23 | 87M | Technology |
Trane Technologies PLC Class A | 2.95 | 79M | Industrials |
Old Dominion Freight Line Inc Ordinary Shares | 2.85 | 76M | Industrials |
Scholar Rock Holding Corp | 2.68 | 72M | Healthcare |
Mirum Pharmaceuticals Inc | 2.44 | 66M | Healthcare |
Toast Inc Class A | 2.32 | 62M | Technology |